Literature DB >> 8943109

Clinical outcome and long-term quality of life after surgical correction of Hirschsprung's disease.

S W Moore1, R Albertyn, S Cywes.   

Abstract

One hundred seventy-eight of 330 patients were recalled after undergoing surgery for histologically proven Hirschsprung's disease (HD). One hundred fifteen were older than 4 years at interview (Mean age, 10 years). This sample appeared to be representative of the whole in terms of demographic features such as ethnic group, sex, length of aganglionic segment, timing of presentation and surgery performed. Anthropomorphic indices for weight and height were comparable to norms, but many younger patients were below expected weight for age. In general, weight and height for age was regained with time. Nine patients had delayed developmental milestones, which were owing to specific causes in four. Nine patients had a poor functional outcome, of which two had neurological impairment. Satisfactory school performance was achieved in all but 19 (26%) of the remaining patients. Long-term functional results were comparable for the Soave and Duhamel procedures with less favorable results noted following the Swenson procedure. Assessment of complications demonstrated a significantly (P < .01) lower incidence of constipation, sexual dysfunction, and micturition disturbance following the Soave procedure when compared with the Duhamel and Swenson procedures. Neurological impairment and length of aganglionic segment beyond the rectosigmoid area appeared to influence functional outcome, as did persisting enterocolitis. Enterocolitis was observed in 16.6% of patients on presentation, but continued in only 6%. Constipation was particularly associated with the Duhamel procedure, and a higher incidence of micturition disturbance, abdominal distension, and cuff stricture was noted following the Swenson procedure. Functional assessment by three different scoring methods showed that 86 (74.7%) of the 115 patients over the age of 4 had excellent anorectal function and appeared to be well adjusted. Twenty-two patients (19.2%) had relatively minor long-term problems but seven (6.1%) had persistent fecal soiling with resulting psychosocial maladjustment.

Entities:  

Mesh:

Year:  1996        PMID: 8943109     DOI: 10.1016/s0022-3468(96)90164-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  36 in total

Review 1.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

Review 2.  Total colonic aganglionosis and Hirschsprung's disease: a review.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2014-10-31       Impact factor: 1.827

3.  Rho-kinase expression in Hirschsprung's disease.

Authors:  David Coyle; Anne Marie O'Donnell; Nicolae Corcionivoschi; John Gillick; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-08-15       Impact factor: 1.827

4.  Redo transanal endorectal pull-through: a preliminary study.

Authors:  T A Gobran; A Ezzat; M E Hassan; J O'Neill
Journal:  Pediatr Surg Int       Date:  2006-12-16       Impact factor: 1.827

5.  Is high amplitude propagated contraction present after transanal endorectal pull-through for Hirschsprung's disease?

Authors:  Miyuki Kohno; Hiromichi Ikawa; Kunio Konuma; Hiroaki Masuyama; Hironori Fukumoto; Eri Morimura
Journal:  Pediatr Surg Int       Date:  2007-10       Impact factor: 1.827

Review 6.  Redo pullthrough for Hirschsprung disease.

Authors:  Matthew W Ralls; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2016-12-31       Impact factor: 1.827

7.  The impact of Down's syndrome on the immediate and long-term outcomes of children with Hirschsprung's disease.

Authors:  Antonino Morabito; Anupam Lall; Sobbia Gull; Amar Mohee; Adrian Bianchi
Journal:  Pediatr Surg Int       Date:  2005-12-14       Impact factor: 1.827

8.  Bowel function and fecal continence after Soave's trans-anal endorectal pull-through for Hirschsprung's disease: a local experience.

Authors:  Ossama M Zakaria
Journal:  Updates Surg       Date:  2012-03-06

9.  Botulinum toxin use in paediatric colorectal surgery.

Authors:  S Basson; P Charlesworth; C Healy; S Phelps; Stewart Cleeve
Journal:  Pediatr Surg Int       Date:  2014-07-06       Impact factor: 1.827

Review 10.  Total colonic aganglionosis and Hirschsprung's disease: shades of the same or different?

Authors:  Sam W Moore
Journal:  Pediatr Surg Int       Date:  2009-07-02       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.